Neurallys startup

Hydrocephalus is a pathology caused by an accumulation of cerebrospinal fuild within the brain and resulting in abnormal intracranial pressure. The most common treatment used today requires surgery to implant a shunt system. Neurallys is developing  a very innovative medical device to improve the quality of life of those patients and provide the neurosurgeons with a new tool for aided-diagnosis and pathology follow-up, with health cost reduction objectives.

Latest News

Neurallys in the Hello Tomorrow’s Top 500 Deeptech Startups

Date: 04-11-2018

Neurallys has been selected as one of @Hello Tomorrow’s Top 500 deeptech startups from over 4,500 applications from 119 countries! Come and meet us at the The Hello Tomorrow Global Summit in Paris on 14-15th March 2019 www.hello-tomorrow.org/summit

Read more

Neurallys, nominated for the “European Neuro Convention 2018, Innovation of the year award”.

Date: 31-05-2018

Neurallys is nominated for the European Neuro Convention 2018, Innovation of the year award. The event will take place during the European Neuro Convention exhibition that will take place the 6 and 7th of June, in London

Read more